Dennis Phillip Andrew
SEC insider (Form 3/4/5 filer). CIK 0002089237. Chief Medical Officer at NovaBridge Biosciences (NBP). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in ROCKVILLE, MD.
Companies Dennis Phillip Andrew has filed insider reports for
- NovaBridge Biosciences (NBP): Officer, Chief Medical Officer
Dennis Phillip Andrew
CIK: 0002089237
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NBP
NovaBridge Biosciences
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 18, 2026NBP
NovaBridge Biosciences
SaleDirect8.2K shares at avg. $0.71$6K - Sep 17, 2026NBP
NovaBridge Biosciences
ExerciseDirect23.7K shares- - Jun 18, 2026NBP
NovaBridge Biosciences
SaleDirect8.5K shares at avg. $0.66$6K - Jun 17, 2026NBP
NovaBridge Biosciences
ExerciseDirect23.7K shares-
1-4 of 4 transactions